SS
HUMA icon

SBI Securities’s Humacyte HUMA Stock Holding History

SBI Securities’s Portfolio HUMA Stock Details HUMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.71K Buy
4,748
+1,075
+29% +$996 ﹤0.01% 2313
2026
Q1 		$2.23K Sell
3,673
-4,132
-53% -$4.3K ﹤0.01% 2382
2025
Q4 		$7.5K Buy
7,805
+5,088
+187% +$7.21K ﹤0.01% 1853
2025
Q3 		$4.73K Sell
2,717
-65,501
-96% -$128K ﹤0.01% 2069
2025
Q2 		$143K Buy
68,218
+67,153
+6,305% +$129K ﹤0.01% 689
2025
Q1 		$1.82K Buy
1,065
+813
+323% +$3.05K ﹤0.01% 2333
2024
Q4 		$1.27K Buy
+252
New +$1.25K ﹤0.01% 2498

Other funds holding HUMA

AP
Antipodes Partners Royal Exchange, Australia $5.46B AUM 26.64% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
DKCM
Davidson Kempner Capital Management New York $8.42B AUM 61.81% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $529M AUM 337.4% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

SBI Securities's HUMA Position: Q2 2026 in Review

SBI Securities increased its Humacyte (HUMA) stake by 29% in Q2 2026, buying an estimated $996 and bringing the position to 4,748 shares worth $3.71K. The position accounts for ﹤0.01% of the portfolio, ranked #2313.

SBI Securities first reported a position in HUMA in Q4 2024 and has held it in 7 quarters since. The position peaked at $143K in Q2 2025. 161 funds tracked by Wall St. Rank hold HUMA as of Q2 2026.

  • SBI Securities held 4,748 shares of Humacyte worth $3.71K as of Q2 2026.
  • SBI Securities bought 1,075 Humacyte shares in Q2 2026, an estimated $996.
  • Humacyte made up ﹤0.01% of SBI Securities's portfolio in Q2 2026, its #2313 holding.
  • SBI Securities first reported a position in Humacyte in Q4 2024 and has held it in 7 quarters since.
  • SBI Securities's Humacyte position peaked at $143K in Q2 2025.
  • 161 funds tracked by Wall St. Rank held Humacyte as of Q2 2026.

Based on SBI Securities's 13F filing for Q2 2026, filed 23 Jul 2026.